Induction of apoptosis by thrombin in the cultured neurons of dorsal motor nucleus of the vagus

Neurogastroenterology and Motility

Volumn 23, Issue 3, 2011, Pages

  Wu, X ^a,b   Zhang, W ^b   Li, J Y ^b   Chai, B X ^b   Peng, J ^a   Wang, H ^a   Mulholland, M W ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Dorsal motor nucleus of vagus; Inflammatory bowel disease; Protease activated receptor

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; HIRUDIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEINASE ACTIVATED RECEPTOR 1 ANTAGONIST; PROTEINASE ACTIVATED RECEPTOR 3 ANTAGONIST; PROTEINASE ACTIVATED RECEPTOR 4 ANTAGONIST; PROTEINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; THROMBIN; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATTENUATION; BRAIN STEM; CONTROLLED STUDY; DRUG EFFECT; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; MICRODISSECTION; MOTONEURON NUCLEUS; NERVE CELL CULTURE; NEWBORN; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; STUDENT T TEST; VAGUS NERVE; VAGUS NERVE NUCLEUS;

ANIMALS; APOPTOSIS; CELLS, CULTURED; IN SITU NICK-END LABELING; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MOTOR NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PAR-1; SIGNAL TRANSDUCTION; THROMBIN; VAGUS NERVE;

EID: 79551696812     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2010.01641.x     Document Type: Article

References (29)

1. Rohatgi T, Henrich-Noack P, Sedehizade F et al. Transient focal ischemia in rat brain differentially regulates mRNA expression of protease-activated receptors 1 to 4. J Neurosci Res 2004; 75: 273-9.
2. Dihanich M, Kaser M, Reinhard E, Cunningham D, Monard D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron 1991; 6: 575-81.
3. Kim S. Characterization of the prothrombin gene expression during nerve differentiation. Biochim Biophys Acta 2004; 1679: 1-9.
4. Striggow F, Riek-Burchardt M, Kiesel A et al. Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur J Neurosci 2001; 14: 595-608.
5. Niclou SP, Suidan HS, Pavlik A, Vejsada R, Monard D. Changes in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesion. Eur J Neurosci 1998; 10: 1590-607.
6. Rogers RC, McCann MJ. Intramedullary connections of the gastric region in the solitary nucleus: a biocytin histochemical tracing study in the rat. J Auton Nerv Syst 1993; 42: 119-30.
7. Wang H, Wu X, Li JY et al. Functional protease-activated receptors in the dorsal motor nucleus of the vagus. Neurogastroenterol Motil 2010; 22: 431-8.
8. Zhang W, Hu Y, Newman EA, Mulholland MW. Serum-free culture of rat postnatal neurons derived from the dorsal motor nucleus of the vagus. J Neurosci Methods 2006; 150: 1-7.
9. Wang H, Ubl JJ, Reiser G. Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia 2002; 37: 53-63.
10. Rohatgi T, Sedehizade F, Reymann KG, Reiser G. Protease-activated receptors in neuronal development, neurodegeneration, and neuroprotection: thrombin as signaling molecule in the brain. Neuroscientist 2004; 10: 501-12.
11. Gorbacheva LR, Storozhevykh TP, Pinelis VG, Ishiwata S, Strukova SM. Modulation of hippocampal neuron survival by thrombin and factor Xa. Biochemistry (Mosc) 2006; 71: 1082-9.
12. Wang Y, Luo W, Reiser G. Activation of protease-activated receptors in astrocytes evokes a novel neuroprotective pathway through release of chemokines of the growth-regulated oncogene/cytokine-induced neutrophil chemoattractant family. Eur J Neurosci 2007; 26: 3159-68.
13. Lee da Y, Park KW, Jin BK. Thrombin induces neurodegeneration and microglial activation in the cortex in vivo and in vitro: proteolytic and non-proteolytic actions. Biochem Biophys Res Commun 2006; 346: 727-38.
14. Choi SH, Lee DY, Ryu JK, Kim J, Joe EH, Jin BK. Thrombin induces nigral dopaminergic neurodegeneration in vivo by altering expression of death-related proteins. Neurobiol dis 2003; 14: 181-93.
15. Gross PM, Wall KM, Pang JJ, Shaver SW, Wainman DS. Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius. Am J Physiol 1990; 259: R1131-8.
16. Hermann GE, Tovar CA, Rogers RC. LPS-induced suppression of gastric motility relieved by TNFR:Fc construct in dorsal vagal complex. Am J Physiol Gastrointest Liver Physiol 2002; 283: G634-9.
17. Hermann GE, Tovar CA, Rogers RC. TNFalpha-stimulation of cFos-activation of neurons in the solitary nucleus is suppressed by TNFR:Fc adsorbant construct in the dorsal vagal complex. Brain Res 2003; 976: 69-74.
18. Hathaway CA, Appleyard CB, Percy WH, Williams JL. Experimental colitis increases blood-brain barrier permeability in rabbits. Am J Physiol 1999; 276: G1174-80.
19. Nguyen C, Coelho AM, Grady E et al. Colitis induced by proteinase-activated receptor-2 agonists is mediated by a neurogenic mechanism. Can J Physiol Pharmacol 2003; 81: 920-7.
20. O'Lynnger T, He Y, Hu H, Hua Y, Muraszko KM, Xi G. Concomitant intracerebral infusion of tissue plasminogen activator and thrombin leads to brain injury. Acta Neurochir Suppl 2008; 105: 55-8.
21. Smirnova IV, Salazar A, Arnold PM, Glatt S, Handler M, Festoff BW. Thrombin and its precursor in human cerebrospinal fluid. Thromb Haemost 1997; 78: 1473-9.
22. Gingrich MB, Traynelis SF. Serine proteases and brain damage - is there a link? Trends Neurosci 2000; 23: 399-407.
23. Souto JC, Martinez E, Roca M et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995; 40: 1883-9.
24. Bustos D, Negri G, De Paula JA et al. Colonic proteinases: increased activity in patients with ulcerative colitis. Medicina (B Aires) 1998; 58: 262-4.
25. Hayat M, Ariens RA, Moayyedi P, Grant PJ, O'Mahony S. Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002; 14: 249-56.
26. Saibeni S, Saladino V, Chantarangkul V et al. Increased thrombin generation in inflammatory bowel diseases. Thromb Res 2010; 125: 278-82.
27. Zezos P, Papaioannou G, Nikolaidis N et al. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis. Med Sci Monit 2009; 15: CR563-72.
28. van Bodegraven AA. Haemostasis in inflammatory bowel diseases: clinical relevance. Scand J Gastroenterol Suppl 2003; 239: 51-62.
29. Thevenet J, Angelillo-Scherrer A, Price M, Hirt L. Coagulation factor Xa activates thrombin in ischemic neural tissue. J Neurochem 2009; 111: 828-36.